GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Effective Interest Rate on Debt %

Biovica International AB (OSTO:BIOVIC B) Effective Interest Rate on Debt % : 44.37% (As of Jul. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Biovica International AB's annualized positive value of Interest Expense for the quarter that ended in Jul. 2024 was kr3.28 Mil. Biovica International AB's average total debt for the quarter that ended in Jul. 2024 was kr7.38 Mil. Therefore, Biovica International AB's annualized Effective Interest Rate on Debt % for the quarter that ended in Jul. 2024 was 44.37%.


Biovica International AB Effective Interest Rate on Debt % Historical Data

The historical data trend for Biovica International AB's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Effective Interest Rate on Debt % Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.83 2.04 1.00 2.37 3.16

Biovica International AB Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.61 19.12 7.64 3.34 44.37

Competitive Comparison of Biovica International AB's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Biovica International AB's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Biovica International AB's Effective Interest Rate on Debt % falls into.



Biovica International AB Effective Interest Rate on Debt % Calculation

Biovica International AB's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Apr. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Apr. 2023 )+Total Debt  (A: Apr. 2024 ))/ count )
=-1  *  -0.289/( (10.453+7.828)/ 2 )
=-1  *  -0.289/9.1405
=3.16 %

where

Total Debt  (A: Apr. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=7.304 + 3.149
=10.453

Total Debt  (A: Apr. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=4.296 + 3.532
=7.828

Biovica International AB's annualized Effective Interest Rate on Debt % for the quarter that ended in Jul. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Apr. 2024 )+Total Debt  (Q: Jul. 2024 ))/ count )
=-1  *  -3.276/( (7.828+6.939)/ 2 )
=-1  *  -3.276/7.3835
=44.37 %

where

Total Debt  (Q: Apr. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=4.296 + 3.532
=7.828

Total Debt  (Q: Jul. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=3.439 + 3.5
=6.939

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Jul. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Biovica International AB  (OSTO:BIOVIC B) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Biovica International AB Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB Headlines

No Headlines